211 related articles for article (PubMed ID: 23055342)
41. High glucose promotes tumor invasion and increases metastasis-associated protein expression in human lung epithelial cells by upregulating heme oxygenase-1 via reactive oxygen species or the TGF-β1/PI3K/Akt signaling pathway.
Kang X; Kong F; Wu X; Ren Y; Wu S; Wu K; Jiang Z; Zhang W
Cell Physiol Biochem; 2015; 35(3):1008-22. PubMed ID: 25661467
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
43. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
44. Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.
Gandini NA; Fermento ME; Salomón DG; Obiol DJ; Andrés NC; Zenklusen JC; Arevalo J; Blasco J; López Romero A; Facchinetti MM; Curino AC
Tumour Biol; 2014 Mar; 35(3):2803-15. PubMed ID: 24234335
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
46. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
47. Pathobiological implications of MUC4 in non-small-cell lung cancer.
Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
[TBL] [Abstract][Full Text] [Related]
48. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
50. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.
Chiou J; Chang YC; Jan YH; Tsai HF; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2019 Oct; 9(1):14624. PubMed ID: 31601833
[TBL] [Abstract][Full Text] [Related]
52. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
53. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
54. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.
Noh SJ; Baek HA; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
Pathol Res Pract; 2013 Jun; 209(6):365-70. PubMed ID: 23702379
[TBL] [Abstract][Full Text] [Related]
55. Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.
Kaira K; Ohde Y; Nakagawa K; Okumura T; Murakami H; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
Med Oncol; 2012 Sep; 29(3):1663-72. PubMed ID: 21948461
[TBL] [Abstract][Full Text] [Related]
56. Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.
Lu DY; Yeh WL; Huang SM; Tang CH; Lin HY; Chou SJ
Neuro Oncol; 2012 Nov; 14(11):1367-78. PubMed ID: 23074199
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
58. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
59. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of miR-5702 is associated with clinical progression and poor prognosis in patients with non-small-cell lung cancer.
Li K; Xu Y; Yuan LN
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2047-2052. PubMed ID: 30915748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
